China Pharma Holdings, Inc. (CPHI)
USD 1.53
(-1.93%)
USD 1.53
(-1.93%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.91 USD | 53.09% |
| 2022 | -1.94 USD | -128.24% |
| 2021 | -0.85 USD | -18.06% |
| 2020 | -0.72 USD | 85.06% |
| 2019 | -4.82 USD | -95.14% |
| 2018 | -2.47 USD | 44.12% |
| 2017 | -4.42 USD | -109.48% |
| 2016 | -2.11 USD | 40.4% |
| 2015 | -3.54 USD | 40.9% |
| 2014 | -5.99 USD | -30.22% |
| 2013 | -4.60 USD | -533.96% |
| 2012 | 1.06 USD | -75.91% |
| 2011 | 4.40 USD | -18.52% |
| 2010 | 5.40 USD | 25.58% |
| 2009 | 4.30 USD | -2.27% |
| 2008 | 4.40 USD | 25.71% |
| 2007 | 3.50 USD | 40.0% |
| 2006 | 2.50 USD | -26.47% |
| 2005 | 3.40 USD | 855.56% |
| 2004 | -0.45 USD | -28.57% |
| 2003 | -0.35 USD | 82.05% |
| 2002 | -1.95 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.07 USD | 39.33% |
| 2024 Q2 | -0.09 USD | -22.53% |
| 2023 Q2 | -0.06 USD | 76.08% |
| 2023 FY | - USD | 53.09% |
| 2023 Q1 | -0.25 USD | -19.05% |
| 2023 Q3 | -0.07 USD | -22.91% |
| 2023 Q4 | -0.12 USD | -63.27% |
| 2022 Q2 | -0.51 USD | 10.53% |
| 2022 Q3 | -0.79 USD | -54.9% |
| 2022 FY | - USD | -128.24% |
| 2022 Q1 | -0.57 USD | 10.94% |
| 2022 Q4 | -0.21 USD | 73.42% |
| 2021 FY | - USD | -18.06% |
| 2021 Q1 | -0.17 USD | 39.29% |
| 2021 Q2 | -0.18 USD | -5.88% |
| 2021 Q3 | -0.18 USD | 0.0% |
| 2021 Q4 | -0.64 USD | -255.56% |
| 2020 Q1 | -0.15 USD | 96.51% |
| 2020 FY | - USD | 85.06% |
| 2020 Q3 | -0.23 USD | -7766.67% |
| 2020 Q2 | 0.00 USD | 102.0% |
| 2020 Q4 | -0.28 USD | -21.74% |
| 2019 Q1 | -0.10 USD | 94.49% |
| 2019 FY | - USD | -95.14% |
| 2019 Q3 | -0.16 USD | 15.79% |
| 2019 Q2 | -0.19 USD | -98.12% |
| 2019 Q4 | -4.30 USD | -2587.5% |
| 2018 FY | - USD | 44.12% |
| 2018 Q4 | -1.74 USD | -304.65% |
| 2018 Q3 | -0.43 USD | -86.96% |
| 2018 Q2 | -0.23 USD | -241.75% |
| 2018 Q1 | -0.07 USD | 97.88% |
| 2017 Q2 | -0.52 USD | -136.36% |
| 2017 Q3 | -0.50 USD | 3.85% |
| 2017 Q4 | -3.17 USD | -534.0% |
| 2017 FY | - USD | -109.48% |
| 2017 Q1 | -0.22 USD | 72.15% |
| 2016 Q4 | -0.79 USD | -97.5% |
| 2016 FY | - USD | 40.4% |
| 2016 Q1 | -0.36 USD | 74.83% |
| 2016 Q2 | -0.56 USD | -55.56% |
| 2016 Q3 | -0.40 USD | 28.57% |
| 2015 Q4 | -1.43 USD | -313.43% |
| 2015 Q2 | -0.94 USD | 50.53% |
| 2015 Q1 | -1.90 USD | 5.0% |
| 2015 FY | - USD | 40.9% |
| 2015 Q3 | 0.67 USD | 171.28% |
| 2014 Q1 | -0.55 USD | 77.08% |
| 2014 Q2 | -2.00 USD | -263.64% |
| 2014 Q3 | -1.50 USD | 25.0% |
| 2014 Q4 | -2.00 USD | -33.33% |
| 2014 FY | - USD | -30.22% |
| 2013 Q1 | -0.65 USD | -124.14% |
| 2013 Q2 | -1.02 USD | -56.92% |
| 2013 Q3 | -0.53 USD | 48.04% |
| 2013 Q4 | -2.40 USD | -352.83% |
| 2013 FY | - USD | -533.96% |
| 2012 Q4 | -0.29 USD | -196.67% |
| 2012 FY | - USD | -75.91% |
| 2012 Q3 | 0.30 USD | -25.0% |
| 2012 Q2 | 0.40 USD | -33.33% |
| 2012 Q1 | 0.60 USD | -55.22% |
| 2011 FY | - USD | -18.52% |
| 2011 Q4 | 1.34 USD | 76.32% |
| 2011 Q3 | 0.76 USD | -36.67% |
| 2011 Q2 | 1.20 USD | 0.0% |
| 2011 Q1 | 1.20 USD | -37.82% |
| 2010 Q4 | 1.93 USD | 37.86% |
| 2010 Q3 | 1.40 USD | 0.0% |
| 2010 FY | - USD | 25.58% |
| 2010 Q2 | 1.40 USD | 27.27% |
| 2010 Q1 | 1.10 USD | -9.09% |
| 2009 Q2 | 1.00 USD | 11.11% |
| 2009 FY | - USD | -2.27% |
| 2009 Q4 | 1.21 USD | -28.82% |
| 2009 Q3 | 1.70 USD | 70.0% |
| 2009 Q1 | 0.90 USD | -32.33% |
| 2008 Q2 | 1.00 USD | -9.09% |
| 2008 Q4 | 1.33 USD | 33.0% |
| 2008 FY | - USD | 25.71% |
| 2008 Q3 | 1.00 USD | 0.0% |
| 2008 Q1 | 1.10 USD | 0.92% |
| 2007 FY | - USD | 40.0% |
| 2007 Q4 | 1.09 USD | 36.25% |
| 2007 Q1 | 0.70 USD | -30.0% |
| 2007 Q2 | 0.90 USD | 28.57% |
| 2007 Q3 | 0.80 USD | -11.11% |
| 2006 Q2 | 0.50 USD | 0.0% |
| 2006 Q1 | 0.50 USD | 0.0% |
| 2006 Q3 | 0.50 USD | 0.0% |
| 2006 Q4 | 1.00 USD | 100.0% |
| 2006 FY | - USD | -26.47% |
| 2005 Q2 | -1.15 USD | -3772.05% |
| 2005 FY | - USD | 855.56% |
| 2005 Q1 | -0.03 USD | -104.83% |
| 2005 Q3 | 0.41 USD | 135.65% |
| 2004 Q3 | -0.01 USD | 87.87% |
| 2004 Q4 | -0.01 USD | -62.92% |
| 2004 FY | - USD | -28.57% |
| 2004 Q2 | -0.07 USD | -173.4% |
| 2004 Q1 | 0.10 USD | 11211.11% |
| 2003 Q4 | -0.00 USD | 99.8% |
| 2003 Q2 | -0.06 USD | 53.85% |
| 2003 Q1 | -0.13 USD | 18.75% |
| 2003 Q3 | -0.44 USD | -633.33% |
| 2003 FY | - USD | 82.05% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | -0.16 USD | -2125.32% |
| 2002 Q3 | 0.01 USD | 100.81% |
| 2002 Q2 | -0.98 USD | -58.06% |
| 2002 Q1 | -0.62 USD | -226.32% |
| 2001 Q4 | -0.19 USD | 44.12% |
| 2001 Q3 | -0.34 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| cbdMD, Inc. | -13.32 USD | 93.168% |
| cbdMD, Inc. | -13.32 USD | 93.168% |
| Zomedica Corp. | -0.04 USD | -2485.227% |